When was Octagon Capital Investments founded?

Octagon Capital Investments was founded in 2009.

Where is Octagon Capital Investments headquartered?

Octagon Capital Investments is headquartered in London, United Kingdom.

What is Octagon Capital Investments's total asset value?

Octagon Capital Investments has around in total assets under management.

How many investments has Octagon Capital Investments made?

Octagon Capital Investments has made 11 investments.

What has Octagon Capital Investments invested in?

Octagon Capital Investments has made numerous investments in companies like Obsidian Therapeutics , Dianthus Therapeutics , and Aktis Oncology within the Drug Discovery industry.

What has Octagon Capital Investments invested in recently?

Octagon Capital Investments's latest investment was on 03-Aug-2026 in Obsidian Therapeutics , a company within the Drug Discovery industry.

Octagon Capital Investments investment portfolio

Octagon Capital Investments Overview

Investor Type

PE/Buyout

Status

Inactive

Investments

11

Portfolio

1

Exits

6

Octagon Capital Investments General Information

Company Description

Founded in 2009, Octagon Capital Investments was a private equity firm based in London, United Kingdom.

Business Details

Website

www.octagoncapitalinvestments.com

Formerly Known As

Octagon Capital Investments PLC

Year Founded

2009

Investor Status

Out of Business

Primary Investor Type

PE/Buyout

Other Investor Types

Growth/Expansion

Venture Capital

Corporate Office

Kemp House
152-160 City Road
London EC1V 2NX
England, United Kingdom

Octagon Capital Investments Investments (11)

Octagon Capital Investments’s most recent investment was a with Obsidian Therapeutics for . The deal was made on 03-Aug-2026.

Company Name	Deal Date	Deal Type	Industry	Company Stage
Obsidian Therapeutics	03-Aug-2026		Drug Discovery	Clinical Trials - Phase 2
Dianthus Therapeutics	24-Jan-2024		Drug Discovery	Generating Revenue
Aktis Oncology	17-Aug-2022		Drug Discovery	Generating Revenue
StrideBio	02-Jun-2022		Drug Discovery	Generating Revenue
Immune-Onc Therapeutics	30-Mar-2021	Later Stage VC	Drug Discovery	Clinical Trials - Phase 2

You’re viewing 5 of 11 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Octagon Capital Investments Exits (6)

Octagon Capital Investments has made a total of 6 exits. Its latest exit was from Aktis Oncology on 13-Feb-2024. The exit was categorized as .

Company Name	Exit Date	Exit Type
Aktis Oncology	13-Feb-2024
StrideBio	05-Apr-2023
Peijia Medical	06-Aug-2021
4D Molecular Therapeutics	11-Dec-2020
Everest Medicines	09-Oct-2020	IPO

You’re viewing 5 of 6 exits. Get the full list »

Octagon Capital Investments Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.